Concomitant Rivaroxaban and Dronedarone Administration in Patients With Nonvalvular Atrial Fibrillation.
Servicio de Cardiología, Hospital Universitario La Paz, IdiPaz, Madrid, Spain.
Carlos
C
Escobar
Servicio de Cardiología, Hospital Universitario La Paz, IdiPaz, Madrid, Spain.
Martín
M
Arceluz
Servicio de Cardiología, Hospital Universitario La Paz, IdiPaz, Madrid, Spain.
Rosa
R
Montes de Oca
Servicio de Cardiología, Hospital Universitario La Paz, IdiPaz, Madrid, Spain.
Ricardo
R
Mori
Unidad de Electrofisiología Robotizada, Hospital Universitario La Paz, IdiPaz, Madrid, Spain.
José Luis
JL
López-Sendón
Servicio de Cardiología, Hospital Universitario La Paz, IdiPaz, Madrid, Spain. Electronic address: jlmerino@secardiologia.es.
José Luis
JL
Merino
D000284:Administration, Oral; D000638:Amiodarone / Q000008:administration & dosage / Q000031:analogs & derivatives*; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000503:physiopathology; D004305:Dose-Response Relationship, Drug; D000077764:Dronedarone; D004359:Drug Therapy, Combination; D065427:Factor Xa Inhibitors / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D000069552:Rivaroxaban / Q000008:administration & dosage*; D020521:Stroke / Q000517:prevention & control*; D016896:Treatment Outcome
D000889:Anti-Arrhythmia Agents; D065427:Factor Xa Inhibitors; D000069552:Rivaroxaban; D000077764:Dronedarone; D000638:Amiodarone